Literature DB >> 31573837

No association between cortical lesions and leptomeningeal enhancement on 7-Tesla MRI in multiple sclerosis.

Mehrnaz Ighani1, Samuel Jonas2, Izlem Izbudak3, Seongjin Choi4, Alfonso Lema-Dopico4, Jun Hua5, Erin E O'Connor6, Daniel M Harrison7.   

Abstract

BACKGROUND: Autopsy data suggest a causative link between meningeal inflammation and cortical lesions (CLs) in multiple sclerosis (MS).
OBJECTIVE: To use leptomeningeal enhancement (LME) and CLs on 7-Tesla (7T) magnetic resonance imaging (MRI) to investigate associations between meningeal inflammation and cortical pathology.
METHODS: Forty-one participants with MS underwent 7T MRI of the brain. CLs and foci of LME were quantified.
RESULTS: All MS participants had CLs; 27 (65.8%) had >1 focus of LME. Except for hippocampal CL count (ρ = 0.32 with spread/fill-sulcal pattern LME, p = 0.042), no significant correlations were seen between LME and CLs. Mean cortical thickness correlated with the number of LME foci (ρ = -0.43, p = 0.005). Participants with relapsing-remitting multiple sclerosis (RRMS) showed no correlation with neocortical CLs, but significant correlations were seen between LME and hippocampal lesion count (ρ = 0.39, p = 0.030), normalized cortical gray matter (GM) volume (ρ = -0.49, p = 0.005), and mean cortical thickness (ρ = -0.59, p < 0.001).
CONCLUSION: This study supports a relationship between LME and cortical GM atrophy but does not support an association of LME and neocortical CLs. This may indicate that meningeal inflammation is involved with neurodegenerative inflammatory processes, rather than focal lesion development.

Entities:  

Keywords:  7T MRI; 7 Tesla; Leptomeningeal enhancement; cortical lesions; hippocampal lesions; meningeal inflammation; multiple sclerosis

Mesh:

Year:  2019        PMID: 31573837      PMCID: PMC7021560          DOI: 10.1177/1352458519876037

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  39 in total

1.  In vivo evidence of disseminated subpial T2* signal changes in multiple sclerosis at 7 T: a surface-based analysis.

Authors:  J Cohen-Adad; T Benner; D Greve; R P Kinkel; A Radding; B Fischl; B R Rosen; C Mainero
Journal:  Neuroimage       Date:  2011-04-13       Impact factor: 6.556

2.  Heterogeneity of Cortical Lesion Susceptibility Mapping in Multiple Sclerosis.

Authors:  M Castellaro; R Magliozzi; A Palombit; M Pitteri; E Silvestri; V Camera; S Montemezzi; F B Pizzini; A Bertoldo; R Reynolds; S Monaco; M Calabrese
Journal:  AJNR Am J Neuroradiol       Date:  2017-04-13       Impact factor: 3.825

3.  A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis.

Authors:  Roberta Magliozzi; Owain W Howell; Cheryl Reeves; Federico Roncaroli; Richard Nicholas; Barbara Serafini; Francesca Aloisi; Richard Reynolds
Journal:  Ann Neurol       Date:  2010-10       Impact factor: 10.422

4.  Inflammatory intrathecal profiles and cortical damage in multiple sclerosis.

Authors:  Roberta Magliozzi; Owain W Howell; Richard Nicholas; Carolina Cruciani; Marco Castellaro; Chiara Romualdi; Stefania Rossi; Marco Pitteri; Maria Donata Benedetti; Alberto Gajofatto; Francesca B Pizzini; Stefania Montemezzi; Sarah Rasia; Ruggero Capra; Alessandra Bertoldo; Francesco Facchiano; Salvatore Monaco; Richard Reynolds; Massimiliano Calabrese
Journal:  Ann Neurol       Date:  2018-04       Impact factor: 10.422

5.  Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis.

Authors:  Owain W Howell; Cheryl A Reeves; Richard Nicholas; Daniele Carassiti; Bishan Radotra; Steve M Gentleman; Barbara Serafini; Francesca Aloisi; Federico Roncaroli; Roberta Magliozzi; Richard Reynolds
Journal:  Brain       Date:  2011-08-11       Impact factor: 13.501

6.  High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis.

Authors:  Klaus Schmierer; Harold G Parkes; Po-Wah So; Shu F An; Sebastian Brandner; Roger J Ordidge; Tarek A Yousry; David H Miller
Journal:  Brain       Date:  2010-01-31       Impact factor: 13.501

7.  Upregulation of immunoglobulin-related genes in cortical sections from multiple sclerosis patients.

Authors:  Øivind Torkildsen; Christine Stansberg; Solveig M Angelskår; Evert-Jan Kooi; Jeroen J G Geurts; Paul van der Valk; Kjell-Morten Myhr; Vidar M Steen; Lars Bø
Journal:  Brain Pathol       Date:  2009-10-16       Impact factor: 6.508

8.  Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology.

Authors:  Roberta Magliozzi; Owain Howell; Abhilash Vora; Barbara Serafini; Richard Nicholas; Maria Puopolo; Richard Reynolds; Francesca Aloisi
Journal:  Brain       Date:  2007-04       Impact factor: 13.501

9.  Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.

Authors:  Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

10.  Leptomeningeal Contrast Enhancement Is Associated with Disability Progression and Grey Matter Atrophy in Multiple Sclerosis.

Authors:  Gleb Makshakov; Evgeniy Magonov; Natalia Totolyan; Vladimir Nazarov; Sergey Lapin; Alexandra Mazing; Elena Verbitskaya; Tatiana Trofimova; Vladimir Krasnov; Maria Shumilina; Alexander Skoromets; Evgeniy Evdoshenko
Journal:  Neurol Res Int       Date:  2017-10-02
View more
  10 in total

1.  Sex-specific differences in rim appearance of multiple sclerosis lesions on quantitative susceptibility mapping.

Authors:  Tolaymat B; Zheng W; Chen H; Choi S; Li X; Harrison Dm
Journal:  Mult Scler Relat Disord       Date:  2020-06-18       Impact factor: 4.339

2.  Cortical lesion hotspots and association of subpial lesions with disability in multiple sclerosis.

Authors:  Erin S Beck; Josefina Maranzano; Nicholas J Luciano; Prasanna Parvathaneni; Stefano Filippini; Mark Morrison; Daniel J Suto; Tianxia Wu; Peter van Gelderen; Jacco A de Zwart; Samson Antel; Dumitru Fetco; Joan Ohayon; Frances Andrada; Yair Mina; Chevaz Thomas; Steve Jacobson; Jeff Duyn; Irene Cortese; Sridar Narayanan; Govind Nair; Pascal Sati; Daniel S Reich
Journal:  Mult Scler       Date:  2022-02-10       Impact factor: 5.855

3.  No Early Effect of Intrathecal Rituximab in Progressive Multiple Sclerosis (EFFRITE Clinical Trial).

Authors:  Mickael Bonnan; Sylvie Ferrari; Henri Courtade; Paul Money; Pauline Desblache; Bruno Barroso; Stéphane Debeugny
Journal:  Mult Scler Int       Date:  2021-03-08

4.  Navigator-Guided Motion and B0 Correction of T2*-Weighted Magnetic Resonance Imaging Improves Multiple Sclerosis Cortical Lesion Detection.

Authors:  Jiaen Liu; Erin S Beck; Stefano Filippini; Peter van Gelderen; Jacco A de Zwart; Gina Norato; Pascal Sati; Omar Al-Louzi; Hadar Kolb; Maxime Donadieu; Mark Morrison; Jeff H Duyn; Daniel S Reich
Journal:  Invest Radiol       Date:  2021-07-01       Impact factor: 10.065

Review 5.  An "Outside-In" and "Inside-Out" Consideration of Complement in the Multiple Sclerosis Brain: Lessons From Development and Neurodegenerative Diseases.

Authors:  B Paul Morgan; Jennifer L Gommerman; Valeria Ramaglia
Journal:  Front Cell Neurosci       Date:  2021-01-07       Impact factor: 5.505

Review 6.  Relevance of Pathogenetic Mechanisms to Clinical Effectiveness of B-Cell-Depleting Monoclonal Antibodies in Multiple Sclerosis.

Authors:  Luca Massacesi; Alice Mariottini; Ferdinando Nicoletti
Journal:  J Clin Med       Date:  2022-07-23       Impact factor: 4.964

7.  Association of retinal atrophy with cortical lesions and leptomeningeal enhancement in multiple sclerosis on 7T MRI.

Authors:  Ryan Mizell; Hegang Chen; Jeffrey Lambe; Shiv Saidha; Daniel M Harrison
Journal:  Mult Scler       Date:  2021-06-14       Impact factor: 6.312

Review 8.  Recent advances in understanding multiple sclerosis.

Authors:  Peter K Stys; Shigeki Tsutsui
Journal:  F1000Res       Date:  2019-12-13

Review 9.  Ultra-high-field 7-T MRI in multiple sclerosis and other demyelinating diseases: from pathology to clinical practice.

Authors:  Nicolo' Bruschi; Giacomo Boffa; Matilde Inglese
Journal:  Eur Radiol Exp       Date:  2020-10-22

Review 10.  CSF enhancement on post-contrast fluid-attenuated inversion recovery images; a systematic review.

Authors:  Whitney M Freeze; Merel van der Thiel; Jeroen de Bresser; Catharina J M Klijn; Ellis S van Etten; Jacobus F A Jansen; Louise van der Weerd; Heidi I L Jacobs; Walter H Backes; Susanne J van Veluw
Journal:  Neuroimage Clin       Date:  2020-10-02       Impact factor: 4.881

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.